Ceribell (CBLL) Short-term Investments (2025 - 2026)
Ceribell's (CBLL) quarterly Short-term Investments came in at $95.9 million in Q1 2026, up 226.97% YoY from $29.3 million in Q1 2025, and down 19.24% on a QoQ basis from $118.8 million in Q4 2025.
Ceribell (CBLL) Short-term Investments (2025 - 2026) Analysis & Trends
Ceribell (CBLL) has 2 years of Short-term Investments data on file, last reported at $95.9 million in Q1 2026.
- Quarterly Short-term Investments rose 226.97% year-over-year to $95.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $95.9 million (up 226.97% YoY) and the FY2025 annual result came in at $118.8 million, changed N/A from the prior year.
- Short-term Investments retreated to $95.9 million in Q1 2026, from $118.8 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $144.8 million in Q3 2025 to a low of $29.3 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Ceribell | 921.14 Mn | 791.87 Mn | 25.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 96.60 Mn |
| Mar 31, 2026 | 95.93 Mn |
| Dec 31, 2025 | 118.79 Mn |
| Sep 30, 2025 | 144.80 Mn |
| Jun 30, 2025 | 137.29 Mn |
| Mar 31, 2025 | 29.34 Mn |